You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pf-00610355

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma, Bronchial, Lung Diseases, Obstructive, Respiratory Tract Diseases Trial (PF-00610355, PF - 00610355, Placebo)

Withdrawn
  • Asthma, Bronchial
  • +3 more
  • PF-00610355
  • +2 more
  • (no location specified)
Jan 29, 2019

Pulmonary Disease, Chronic Obstructive, Lung Diseases, Lung Diseases, Obstructive Trial in Worldwide (PF-00610355, PF -

Completed
  • Pulmonary Disease, Chronic Obstructive
  • +2 more
  • PF-00610355
  • +4 more
  • Fairhope, Alabama
  • +74 more
Feb 1, 2019

Pulmonary Disease, Lung Disease, Moxifloxacin Trial in Bruxelles (PF-00610355, moxifloxacin, )

Completed
  • Pulmonary Disease
  • +2 more
  • PF-00610355
  • +2 more
  • Bruxelles, Belgium
    Pfizer Investigational Site
Jan 12, 2011

Pulmonary Disease, Chronic Obstructive Trial in Berlin, Wiesbaden (PF-00610355, Placebo)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • PF-00610355
  • Placebo
  • Berlin, Germany
  • +1 more
Oct 27, 2010